Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
41 studies found for:    "Herpes Labialis"
Show Display Options
Rank Status Study
1 Unknown  NB-001 Treatment of Recurrent Herpes Labialis
Condition: Herpes Labialis
Interventions: Drug: NB-001 (0.3%);   Drug: Placebo
2 Completed Study to Evaluate Using a Cold Sore Patch to Treat Herpes Labialis
Condition: Herpes Labialis
Intervention: Device: Cold Sore Patch
3 Completed Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis
Condition: Herpes Labialis
Intervention: Drug: NB-001
4 Completed Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
Condition: Herpes Labialis
Intervention: Drug: Famciclovir
5 Completed Botulinum Toxin A for Herpes Labialis
Condition: Herpes Labialis
Interventions: Drug: onabotulinumtoxinA;   Other: Bacteriostatic normal saline
6 Completed A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis
Condition: Recurrent Herpes Labialis
Intervention: Drug: Famciclovir
7 Completed Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis
Condition: Herpes Labialis
Interventions: Drug: ME-609;   Drug: Vehicle
8 Completed
Has Results
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
Condition: Herpes Labialis
Intervention: Drug: acyclovir/hydrocortisone cream
9 Recruiting Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores
Condition: Herpes Labialis
Interventions: Drug: ZEP-3 ointment 1.0%;   Drug: Acyclovir cream 5%
10 Completed Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis
Condition: Herpes Labialis
Intervention: Device: iontophoretic acyclovir
11 Completed
Has Results
Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores
Condition: Recurrent Herpes Labialis
Interventions: Drug: ethanol/glycolic acid solution;   Drug: Placebo/Ethanol
12 Completed Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis
Condition: Herpes Labialis
Intervention: Drug: valacyclovir+clobetasol gel
13 Completed Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Condition: Herpes Labialis
Interventions: Drug: Squaric Acid solution;   Drug: Placebo solution
14 Completed Study of a Cold Sore Patch for the Treatment of Herpes Labialis
Condition: Herpes Labialis
Intervention: Device: Patch ( Compeed© Total CareTM Cold Sore Patch)
15 Recruiting Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis
Condition: Herpes Labialis
Interventions: Other: BOR15001L7;   Other: Placebo
16 Completed Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis
Condition: Herpes Labialis
Interventions: Drug: Acyclovir 50mg/g;   Drug: Penciclovir 10mg/g
17 Completed Iontophoretic Application of Acyclovir Gel to Treat Cold Sores
Condition: Herpes Labialis
Intervention: Drug: Iontophoretic delivery of acyclovir
18 Completed
Has Results
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
Condition: Herpes Labialis
Interventions: Device: Acyclovir patch;   Device: Placebo patch
19 Completed Place Controlled Study to Treat Recurrent Herpes Labialis.
Condition: Recurrent Herpes Labialis
Intervention: Drug: Ointment
20 Completed A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)
Condition: Recurrent Herpes Labialis
Interventions: Drug: NB-001;   Drug: Vehicle

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.